申请人:Bayer Aktiengesellschaft
公开号:US05859053A1
公开(公告)日:1999-01-12
The invention relates to new derivatives of acetylsalicylic acid (called ASA in the following), which contain an NO.sub.3 structure. They are therapeutically active either as the intact active compound molecule or after cleavage (NO release). The invention also relates to processes for their preparation and their use as medicaments, in particular for the alleviation of pain, inhibition of platelet aggregation, lowering of fever and for the prevention of cardiovascular disorders and oncoses.
本发明涉及水杨酸乙酯(以下称为ASA)的新衍生物,它们含有NO3结构。它们作为完整的活性化合物分子或裂解后(NO释放)具有治疗活性。本发明还涉及它们的制备方法以及作为药物的使用,特别是用于缓解疼痛、抑制血小板聚集、降低发烧以及预防心血管疾病和肿瘤。